Anzeige
Mehr »
Login
Freitag, 24.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
InnoCan Pharma: Jetzt in die Doppel-Chance investieren?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema NEUBASE THERAPEUTICS

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
MiNeuBase Therapeutics, Inc. - 8-K, Current Report-
16.05.NSE - NeuBase Therapeutics, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities2
15.05.Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. from The Nasdaq Stock Market99NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.'s securities were suspended...
► Artikel lesen
13.05.NeuBase Therapeutics, Inc. - 8-K, Current Report4
03.05.NeuBase Therapeutics, Inc. - 8-K, Current Report1
05.04.NeuBase Therapeutics announces receipt of Nasdaq notice3
05.04.NeuBase Therapeutics, Inc. - 8-K, Current Report2
05.04.NeuBase Therapeutics, Inc.: NeuBase Therapeutics Announces Receipt of Notice from Nasdaq401PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company") today reported that it received a notice (the "Notice) on April 4, 2024 from the...
► Artikel lesen
26.03.Why Neubase Therapeutics (NBSE) Shares Are Nosediving3
26.03.NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare movers4
26.03.Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?4
07.03.NeuBase Therapeutics, Inc. - 8-K, Current Report4
23.02.NeuBase Therapeutics, Inc. - 8-K, Current Report8
26.01.NeuBase Therapeutics, Inc. - 8-K, Current Report2
17.01.NeuBase Therapeutics, Inc. - 8-K, Current Report1
22.12.23NeuBase Therapeutics, Inc. - 8-K, Current Report4